Relay-Version: version B 2.10 5/3/83; site utzoo.UUCP Posting-Version: version B 2.10.2 9/18/84 exptools; site hlexa.UUCP Path: utzoo!watmath!clyde!burl!ulysses!mhuxr!mhuxj!mhuxh!hlexa!hsf From: hsf@hlexa.UUCP (Henry Friedman) Newsgroups: net.med Subject: Medical breakthroughs Message-ID: <4453@hlexa.UUCP> Date: Mon, 22-Jul-85 11:50:05 EDT Article-I.D.: hlexa.4453 Posted: Mon Jul 22 11:50:05 1985 Date-Received: Wed, 24-Jul-85 23:42:59 EDT Distribution: net Organization: AT&T Bell Laboratories, Short Hills, NJ Lines: 38 It appears that we are on the verge of major breakthroughs in the treatment of heart disease and cancer. If initial favorable indications prove out, these breakthroughs presage a significant improvement in human longevity. In the area of heart disease, the breakthrough is an improved enzyme (TPA ?) for dissolving clots. The new drug and procedure (pending final approval) is simpler and more effective than the current procedure, which employs arterial catheterization and streptokinase. The new drug could be injected by a paramedic while enroute to the ER. If given within a few hours of an attack, it is said to almost completely prevent permanent heart damage. In the area of cancer treatment, advances in basic scientific understanding (oncogene mechanism), experimental drug testing and genetic engineering are about to come together in a meaningful way. Natural bodily anticancer agents are being identified, and gene splicing techniques are making economic production of these agents feasible for the first time. For example, the natural anticancer agent Tumor Necrosis Factor (TNF) was identified some years ago, but effective use wasn't feasible until gene splicing techniques made large-scale production economically possible. Indications are that initial human tests (in Japan) of a combination of interferon and TNF show promise. The interferon is also produced by gene splicing techniques, using bacteria as "factories." Monoclonal antibodies, also a product of genetic engineering research, is another promising area of cancer treatment. I post this to invite further discussion, comment, correction, etc. When these breakthroughs in treatment are ADDED to what we're learning about prevention, major enhancements in life span and quality of life should result. --Henry Friedman